ACTIVE SUBSTANCE / INN

TREPROSTINIL DIOLAMINE

Brand name(s): ORENITRAM, Orepaxam
FDA LISTED
EMA LISTED
PRESCRIPTION
APPLICATION WITHDRAWN
NDA203496
Hypertension, Pulmonary
ACTIVE SUBSTANCE
Treprostinil Diolamine
REGULATORS
FDA · EMA
SPONSORS / MAH
Ferrer Internacional S.A., UNITED THERAP
TOTAL APPLICATIONS
2
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
ORENITRAMNDA203496UNITED THERAPPrescription
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
OrepaxamFerrer Internacional S.A.Application withdrawnHypertension, Pulmonary

FULL INTELLIGENCE ON TREPROSTINIL DIOLAMINE

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →